EyePoint Pharmaceuticals ...

NASDAQ: EYPT · Real-Time Price · USD
11.32
0.23 (2.07%)
At close: Aug 18, 2025, 3:59 PM
11.33
0.09%
After-hours: Aug 18, 2025, 04:10 PM EDT

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals reported an annual revenue of $43.27M, reflecting a -5.97% growth. For the quarter ending June 30, 2025, EyePoint Pharmaceuticals generated $5.33M in revenue.
Revenue (ttm)
43.27M
Revenue Growth
-5.97%
Price / Sales Ratio
9.69
Revenue / Employee
262.26K
Employees
165
Market Cap
780.26M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 43.27M -5.97%
Dec 31, 2023 46.02M +11.14%
Dec 31, 2022 41.4M +12.09%
Dec 31, 2021 36.94M +7.27%
Dec 31, 2020 34.44M +69.10%
Dec 31, 2019 20.36M +587.77%
Jun 30, 2018 2.96M -60.72%
Jun 30, 2017 7.54M +365.37%
Jun 30, 2016 1.62M -93.90%
Jun 30, 2015 26.57M +664.90%
Jun 30, 2014 3.47M +62.06%
Jun 30, 2013 2.14M -39.22%
Jun 30, 2012 3.53M -28.98%
Jun 30, 2011 4.96M -78.46%
Jun 30, 2010 23.05M +89.55%
Jun 30, 2009 12.16M +249.88%
Jun 30, 2008 3.48M +55.53%
Jun 30, 2007 2.23M +52.52%
Jun 30, 2006 1.47M +132.78%
Jun 30, 2005 629.52K +137.35%
Jun 30, 2004 265.23K +256.73%
Jun 30, 2003 74.35K -85.60%
Jun 30, 2002 516.32K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.